273 related articles for article (PubMed ID: 16680581)
21. Active Surveillance versus Surgery of Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤2 cm in MEN1 Patients.
Partelli S; Tamburrino D; Lopez C; Albers M; Milanetto AC; Pasquali C; Manzoni M; Toumpanakis C; Fusai G; Bartsch D; Falconi M
Neuroendocrinology; 2016; 103(6):779-86. PubMed ID: 26731608
[TBL] [Abstract][Full Text] [Related]
22. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
[TBL] [Abstract][Full Text] [Related]
23. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection.
Norton JA; Harris EJ; Chen Y; Visser BC; Poultsides GA; Kunz PC; Fisher GA; Jensen RT
Arch Surg; 2011 Jun; 146(6):724-32. PubMed ID: 21690450
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
26. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.
Falconi M; Zerbi A; Crippa S; Balzano G; Boninsegna L; Capitanio V; Bassi C; Di Carlo V; Pederzoli P
Ann Surg Oncol; 2010 Jun; 17(6):1621-7. PubMed ID: 20162460
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.
Gibril F; Venzon DJ; Ojeaburu JV; Bashir S; Jensen RT
J Clin Endocrinol Metab; 2001 Nov; 86(11):5282-93. PubMed ID: 11701693
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and surgical treatment of pancreatic endocrine tumors in 36 patients: a single-center report.
Liu H; Zhang SZ; Wu YL; Fang HQ; Li JT; Sheng HW; Wang Y
Chin Med J (Engl); 2007 Sep; 120(17):1487-90. PubMed ID: 17908455
[TBL] [Abstract][Full Text] [Related]
29. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
30. [Pancreatic endocrine tumors].
Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
[TBL] [Abstract][Full Text] [Related]
31. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1.
Gauger PG; Scheiman JM; Wamsteker EJ; Richards ML; Doherty GM; Thompson NW
Br J Surg; 2003 Jun; 90(6):748-54. PubMed ID: 12808627
[TBL] [Abstract][Full Text] [Related]
32. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
[TBL] [Abstract][Full Text] [Related]
33. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
[TBL] [Abstract][Full Text] [Related]
34. Central pancreatectomy: single-center experience of 50 cases.
Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
[TBL] [Abstract][Full Text] [Related]
35. [Surgery for pancreatic neuroendocrine tumors].
Shibata C; Egawa S; Motoi F; Morikawa T; Naitoh T; Unno M; Sasaki I
Nihon Geka Gakkai Zasshi; 2012 Nov; 113(6):502-6. PubMed ID: 23330458
[TBL] [Abstract][Full Text] [Related]
36. Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
Surgery; 2017 Mar; 161(3):727-734. PubMed ID: 27863775
[TBL] [Abstract][Full Text] [Related]
37. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
39. Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
Klein Haneveld MJ; van Treijen MJC; Pieterman CRC; Dekkers OM; van de Ven A; de Herder WW; Zandee WT; Drent ML; Bisschop PH; Havekes B; Vriens MR; Verrijn Stuart AA; Valk GD; van Leeuwaarde RS
J Clin Endocrinol Metab; 2021 Nov; 106(12):3515-3525. PubMed ID: 34333645
[TBL] [Abstract][Full Text] [Related]
40. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
Albers MB; Manoharan J; Bollmann C; Chlosta MP; Holzer K; Bartsch DK
World J Surg; 2019 Feb; 43(2):552-558. PubMed ID: 30288555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
